PERCEPTIVE ADVISORS LLC 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:38 pm Purchase | 2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 28,057,456 9.600% | 414,539 (+1.50%) | Filing |
| 2023-02-14 2:31 pm Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 27,642,917 9.800% | 286,874 (+1.05%) | Filing |
| 2022-03-02 4:16 pm Sale | 2022-02-23 | 13G | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 27,356,043 9.700% | -400 (-0.00%) | Filing |
| 2022-03-02 3:38 pm Purchase | 2022-02-23 | 13D | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 27,356,443 9.700% | 797,000 (+3.00%) | Filing |
| 2022-02-22 5:19 pm Unchanged | 2021-07-02 | 13D | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 26,559,443 9.500% | 0 (Unchanged) | Filing |
| 2022-02-14 3:45 pm Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 26,559,443 9.500% | 1,447,395 (+5.76%) | Filing |
| 2021-02-16 3:33 pm Sale | 2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 25,112,048 9.700% | -20,316 (-0.08%) | Filing |
| 2020-02-14 4:01 pm Purchase | 2019-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 25,132,364 9.900% | 4,407,940 (+21.27%) | Filing |